SARS-CoV-2分子检测外部质量评估方案的技术与健康治理:区域卫生服务机构所有临床实验室的实践经验
作为区域参考中心,CRQ实验室开发并实施了一套外部质量评估(EQA)检测面板,用于评估62家西西里实验室(经授权可出具COVID-19诊断证书)的实时逆转录PCR检测质量。定性性能测试基于不同病毒载量的SARS-CoV-2或人冠状病毒OC43的混合样本。75%的参与实验室正确检测了所有核心样本,其余25%对EQA样本的解读错误,与所需标准不符。后续检查访问确认,尽管私立和公立实验室拥有现行法规要求的授权条件,仍存在 incorrect 的COVID-19阳性和阴性认证问题,对区域卫生服务(SSR)产生重大影响。
要点
- 75%的参与实验室在EQA中所有核心样本检测正确。
- 25%的实验室对EQA样本解读错误,与标准不符。
- 后续检查确认部分实验室存在错误的COVID-19阴阳性认证。
核心结论
- EQA显示75%的实验室检测正确,但25%的实验室解读错误,后续检查确认了错误认证问题,对区域卫生服务有重大影响。
研究设计与样本
- CRQ实验室作为区域参考中心,开发并实施了EQA面板,评估62家西西里授权实验室的实时逆转录PCR检测质量。
主要发现
- 定性性能测试基于不同病毒载量的SARS-CoV-2或人冠状病毒OC43的混合样本。
- 75%的参与实验室正确检测了所有核心样本,25%的实验室解读错误。
- 后续检查访问确认了私立和公立实验室存在错误的COVID-19阳性和阴性认证。
关键数值与推荐
- EQA定性性能测试使用不同病毒载量的SARS-CoV-2或人冠状病毒OC43的混合样本。
- 75%的实验室所有核心样本检测正确,25%的实验室解读错误。
临床怎么用
- EQA可用于评估实验室SARS-CoV-2分子检测质量,识别解读错误并触发后续检查。
- 后续检查应确认实验室认证的准确性,即使实验室持有授权要求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Since December 2019, the worldwide public health has been threatened by a severe acute respiratory syndrome caused by Coronavirus-2. From the beginning, a turning point has been the identification of new cases of infection, in order to minimize the virus spreading among the population. For this reason, it was necessary introducing a panel of tests able to identify positive cases, which became crucial for all countries. METHODS: As a Regional Reference Centre, the CRQ Laboratory (Regional Laboratory for the Quality Control) developed and conducted an External Quality Assessment (EQA) panel of assay, so as to evaluate the quality of real-time reverse transcription polymerase chain reaction (PCR), which were used by 62 Sicilian laboratories, previously authorized to issue certificates for the COVID-19 diagnosis, on behalf of the Public Health Service. RESULTS: The qualitative performance test was based on pooled samples with different viral loads of SARS-CoV-2 or human Coronavirus OC43. 75% of the participating laboratories tested all core samples correctly, while the remaining 25% interpreted incorrectly the EQA exercise samples matching negatively the standards required. CONCLUSIONS: Subsequent inspection visits confirmed the issue of incorrect positive and negative certifications for COVID-19 by private and public laboratories, despite the possession of the authorization requirements currently provided for by current regulations, with a significant impact on the SSR.
引用
- Di Gaudio F, Brunacci G, Contino F, et al. Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service. Clin Chem Lab Med. 2022. PMID: 36114825. doi:10.1515/cclm-2022-0780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。